<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00069576</url>
  </required_header>
  <id_info>
    <org_study_id>HD36801 - GDM</org_study_id>
    <secondary_id>U10HD021410</secondary_id>
    <secondary_id>U10HD027869</secondary_id>
    <secondary_id>U10HD027917</secondary_id>
    <secondary_id>U10HD027915</secondary_id>
    <secondary_id>U10HD034116</secondary_id>
    <secondary_id>U10HD034208</secondary_id>
    <secondary_id>U10HD040500</secondary_id>
    <secondary_id>U10HD040485</secondary_id>
    <secondary_id>U10HD040544</secondary_id>
    <secondary_id>U10HD040545</secondary_id>
    <secondary_id>U10HD040560</secondary_id>
    <secondary_id>U10HD040512</secondary_id>
    <secondary_id>U10HD036801</secondary_id>
    <secondary_id>U10HD053118</secondary_id>
    <secondary_id>U10HD053097</secondary_id>
    <secondary_id>U10HD027860</secondary_id>
    <secondary_id>U10HD034136</secondary_id>
    <nct_id>NCT00069576</nct_id>
  </id_info>
  <brief_title>Gestational Diabetes Mellitus Trial (GDM)</brief_title>
  <acronym>GDM</acronym>
  <official_title>A Randomized Clinical Trial of Treatment for Mild Gestational Diabetes Mellitus</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The George Washington University Biostatistics Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>The George Washington University Biostatistics Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Gestational diabetes mellitus (GDM) is a type of diabetes (high blood sugar) that occurs in
      pregnant women. This study will determine whether treating pregnant women who have mild GDM
      improves the health of their babies. The follow-up study will examine whether factors during
      the previous pregnancy (such as blood sugar during pregnancy) are associated with the woman
      and her child's health 4-9 years later.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Gestational diabetes mellitus is defined as glucose intolerance of variable severity with
      onset or first recognition during pregnancy. The definition applies regardless of insulin use
      for treatment or the persistence of the condition after pregnancy, and does not exclude the
      possibility that unrecognized glucose intolerance or overt diabetes may have preceded the
      pregnancy. Pre-existing diabetes substantially contributes to perinatal morbidity and
      mortality. The association of milder forms of gestational diabetes with adverse pregnancy
      outcomes, including morbidities such as macrosomia, birth trauma, and neonatal hypoglycemia,
      remains questionable. While it is likely that maternal glucose intolerances reflect a
      continuum of risk for adverse outcomes, it is not known whether there is a benefit to
      identification and subsequent treatment of mild glucose intolerance during pregnancy. This
      study will determine whether dietary treatment (and insulin as required) for mild GDM will
      reduce the frequency of neonatal morbidity associated with mild glucose intolerance.

      Participants in this study will receive a 50-gram glucose loading test (GLT) between 24 and
      30 weeks' gestation. Those with a positive GLT will receive a subsequent 3-hour oral glucose
      tolerance test (OGTT). Based upon these test results, women will be assigned to 4 groups.
      Women with a positive GLT and abnormal OGTT will be randomly assigned to receive either
      nutritional counseling and diet therapy (Group 1) or no specific treatment (Group 2a). Women
      with a positive GLT but normal OGTT will be enrolled in Group 2b for observation. Women with
      a negative GLT will be enrolled in Group 3 and will serve as a control group.

      Women in Group 1 will receive formal nutritional counseling and will be instructed on the
      techniques of self blood glucose monitoring. Patients will take daily blood glucose
      measurements and will be seen at weekly study visits. The study will evaluate birth outcomes,
      including stillbirth, neonatal hypoglycemia, neonatal hyperinsulinemia, neonatal
      hyperbilirubinemia, and birth trauma.

      The follow-up study will examine if blood sugar levels and treatments during pregnancy
      influence the health of the mother and child several years later. The study will also examine
      whether there is a genetic link to the health of the mother and child. The study visit will
      include blood pressure, body size measurements, blood draw and saliva collection, and
      questions related to the mother and child's health and environment.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2002</start_date>
  <completion_date type="Actual">October 2013</completion_date>
  <primary_completion_date type="Actual">November 2007</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Participants With Composite Neonatal Morbidity</measure>
    <time_frame>Delivery through discharge of infant from hospital up to 120 days</time_frame>
    <description>The composite perinatal outcome included stillbirth, neonatal death, hypoglycemia, hyperbilirubinemia, elevated cordblood C-peptide level, and birth trauma.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Children at the 5-10 Year Followup With BMI ≥ 95th Percentile for Age and Sex</measure>
    <time_frame>Age 5-10 years</time_frame>
    <description>Number of children with BMI ≥ 95th percentile for age and sex. BMI is measured as kg / m^2. Standards based on the 2000 Centers for Disease Control growth charts.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of Neonates Who Were Large for Gestational Age at Delivery</measure>
    <time_frame>From time of randomization through delivery (up to 17 weeks)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Neonates With Macrosomia (Birth Weight &gt; 4000 gm)</measure>
    <time_frame>Assessed at Delivery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number Participants Who Delivered Preterm</measure>
    <time_frame>Delivery before 37 weeks gestation</time_frame>
    <description>Number of preterm deliveries before 37 weeks gestation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean Neonatal Fat Mass at Delivery</measure>
    <time_frame>Assessed at delivery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Neonates Who Were Small for Gestational Age</measure>
    <time_frame>From time of randomization through delivery (up to 17 weeks)</time_frame>
    <description>Birth weight below the 10th percentile</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean Neonatal Birth Weight</measure>
    <time_frame>Assessed at delivery</time_frame>
    <description>Birth weight in grams</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Infants Admitted to NICU</measure>
    <time_frame>Delivery through hospital discharge up to 120 days</time_frame>
    <description>Admission to the Neonatal Intensive Care Unit</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Neonates Who Received Intravenous Glucose Treatment</measure>
    <time_frame>Delivery through hospital discharge up to 120 days</time_frame>
    <description>Number of neonates who received intravenous glucose treatment at any time from delivery through hospital discharge.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Neonates Who Experienced Respiratory Distress Syndrome</measure>
    <time_frame>Delivery through hospital discharge up to 120 days</time_frame>
    <description>Number of neonates who experienced Respiratory Distress Syndrome at any time from delivery through hospital discharge</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants Who Underwent Labor Induction</measure>
    <time_frame>From time of randomization through induction (up to 17 weeks)</time_frame>
    <description>Number of participants who underwent labor induction</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants Who Underwent Cesarean Delivery</measure>
    <time_frame>Delivery</time_frame>
    <description>Delivery by cesarean section</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Neonates Who Experienced Shoulder Dystocia</measure>
    <time_frame>During the process of labor through delivery</time_frame>
    <description>Number of neonates who experienced shoulder dystocia during labor and delivery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants Who Experienced Preeclampsia</measure>
    <time_frame>From time of randomization through delivery (up to 17 weeks)</time_frame>
    <description>Number of participants who experienced preeclampsia</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants Who Had Preeclampsia or Gestational Hypertension</measure>
    <time_frame>From time of randomization through delivery (up to 17 weeks)</time_frame>
    <description>Number of participants who had Preeclampsia or gestational hypertension</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean Maternal Body-mass Index at Delivery</measure>
    <time_frame>Delivery</time_frame>
    <description>Mean maternal body-mass index at the time of delivery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean Maternal Weight Gain</measure>
    <time_frame>From time of randomization through delivery (up to 17 weeks)</time_frame>
    <description>Mean Maternal weight gain from enrollment in the trial until delivery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Children With BMI ≥ 85th Percentile for Age and Sex</measure>
    <time_frame>Age 5-10 years</time_frame>
    <description>Number of children with BMI ≥ 85th percentile for age and sex at the 5-10 year follow-up. BMI is measured as kg/m^2. Standards base on the 2000 Centers for Disease Control growth charts.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Children at 5-10 Year Follow up With Waist Circumference &gt;90th Percentile for Age, Sex and Race/Ethnicity</measure>
    <time_frame>Age 5-10 years</time_frame>
    <description>Child waist circumference &gt;90th percentile for age, sex and race/ethnicity based on a study examining cross-sectional data from the Third National Health and Nutrition Examination Survey (NHANES III)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Children at 5-10 Year Follow up With Hypertension ≥ 95th Percentile for Age, Sex and Height</measure>
    <time_frame>Age 5 - 10 years</time_frame>
    <description>Hypertension ≥ 95th percentile for age, sex and height based on the National Heart, Lung and Blood Institute Expert Panel on Integrated Guidelines for Children and Adolescents.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Children at 5-10 Year Follow-up With Impaired Fasting Glucose ≥100 mg/dL</measure>
    <time_frame>Age 5-10 years</time_frame>
    <description>Number of children at 5-10 year follow-up with impaired fasting glucose ≥100 mg/dL</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Mean Gestational Age at Birth</measure>
    <time_frame>Delivery</time_frame>
    <description>Mean Gestational age at the time of delivery</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">7381</enrollment>
  <condition>Diabetes, Gestational</condition>
  <arm_group>
    <arm_group_label>Nutritional counseling &amp; self blood glucose monitoring</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Within one week of enrollment, women in the treatment group receive formal nutritional counseling and will be instructed on the technique of self blood glucose monitoring using a memory-based reflectance meter.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No treatment</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>This group will not receive any specific dietary therapy except for written information concerning general nutritional recommendations for normal pregnancy.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>nutritional counseling</intervention_name>
    <arm_group_label>Nutritional counseling &amp; self blood glucose monitoring</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>self blood glucose monitoring</intervention_name>
    <arm_group_label>Nutritional counseling &amp; self blood glucose monitoring</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Pregnant

          -  Gestational age at enrollment 24 - 31 weeks

        Exclusion Criteria:

          -  Diabetes diagnosed prior to pregnancy

          -  Abnormal gestational diabetes (&gt;= 135 mg/dl) testing prior to 24 weeks' gestation

          -  Gestational diabetes in a previous pregnancy

          -  History of stillbirth or fetal death

          -  Pregnancy with more than one fetus

          -  Known major fetal anomaly

          -  Current or planned corticosteroid therapy

          -  Asthma requiring medication

          -  Current or planned beta adrenergic therapy

          -  Chronic hypertension requiring medication within 6 months of or during pregnancy

          -  Chronic medical conditions such as HIV/AIDS, kidney disease, or congenital heart
             disease

          -  Hematologic or autoimmune disease such as sickle cell disease, other
             hemoglobinopathies, lupus, or antiphospholipid syndrome

          -  Maternal or fetal conditions likely to require preterm delivery, such as
             pre-eclampsia, preterm labor, or intrauterine growth retardation

          -  Previous or planned tocolytic therapy to induce labor or increase contraction strength
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mark B. Landon, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Ohio State University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Uma Reddy, MD, MPH</last_name>
    <role>Study Director</role>
    <affiliation>Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Elizabeth A Thom, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>George Washington University Biostatistics Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Alabama at Birmingham</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35233</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Northwestern University</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60611</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wayne State University - Hutzel Hospital</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48201</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Columbia University-St. Luke's Hospital</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10032</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of North Carolina-Chapel Hill</name>
      <address>
        <city>Chapel Hill</city>
        <state>North Carolina</state>
        <zip>17599</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wake Forest University School of Medicine</name>
      <address>
        <city>Winston-Salem</city>
        <state>North Carolina</state>
        <zip>27157</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Case Western Reserve University</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44109</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ohio State University Hospital</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43210</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Oregon Health and Science University</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97239</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Drexel University</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19107</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Pittsburgh-Magee Womens Hospital</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15213</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Brown University</name>
      <address>
        <city>Providence</city>
        <state>Rhode Island</state>
        <zip>02905</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Texas Southwestern Medical Center</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75235</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Texas Medical Branch</name>
      <address>
        <city>Galveston</city>
        <state>Texas</state>
        <zip>77555</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Texas-Houston</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Utah</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84132</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.bsc.gwu.edu/mfmu</url>
    <description>NICHD Maternal Fetal Medicine Units Network website</description>
  </link>
  <reference>
    <citation>Landon MB, Thom E, Spong CY, Gabbe SG, Leindecker S, Johnson F, Lain K, Miodovnik M, Carpenter M. A planned randomized clinical trial of treatment for mild gestational diabetes mellitus. J Matern Fetal Neonatal Med. 2002 Apr;11(4):226-31.</citation>
    <PMID>12375675</PMID>
  </reference>
  <reference>
    <citation>Landon MB, Mele L, Spong CY, Carpenter MW, Ramin SM, Casey B, Wapner RJ, Varner MW, Rouse DJ, Thorp JM Jr, Sciscione A, Catalano P, Harper M, Saade G, Caritis SN, Sorokin Y, Peaceman AM, Tolosa JE, Anderson GD; Eunice Kennedy Shriver National Institute of Child Health, and Human Development (NICHD) Maternal–Fetal Medicine Units (MFMU) Network. The relationship between maternal glycemia and perinatal outcome. Obstet Gynecol. 2011 Feb;117(2 Pt 1):218-24.</citation>
    <PMID>21309194</PMID>
  </reference>
  <reference>
    <citation>Durnwald CP, Mele L, Spong CY, Ramin SM, Varner MW, Rouse DJ, Sciscione A, Catalano P, Saade G, Sorokin Y, Tolosa JE, Casey B, Anderson GD; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Maternal-Fetal Medicine Units Network (MFMU). Glycemic characteristics and neonatal outcomes of women treated for mild gestational diabetes. Obstet Gynecol. 2011 Apr;117(4):819-27. doi: 10.1097/AOG.0b013e31820fc6cf.</citation>
    <PMID>21422852</PMID>
  </reference>
  <reference>
    <citation>Bahado-Singh RO, Mele L, Landon MB, Ramin SM, Carpenter MW, Casey B, Wapner RJ, Varner MW, Rouse DJ, Thorp JM Jr, Sciscione A, Catalano P, Harper M, Saade G, Caritis SN, Peaceman AM, Tolosa JE; Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-fetal Medicine Units Network. Fetal male gender and the benefits of treatment of mild gestational diabetes mellitus. Am J Obstet Gynecol. 2012 May;206(5):422.e1-5. doi: 10.1016/j.ajog.2012.03.015. Epub 2012 Mar 23.</citation>
    <PMID>22542118</PMID>
  </reference>
  <reference>
    <citation>Stuebe AM, Landon MB, Lai Y, Spong CY, Carpenter MW, Ramin SM, Casey B, Wapner RJ, Varner MW, Rouse DJ, Sciscione A, Catalano P, Harper M, Saade G, Sorokin Y, Peaceman AM, Tolosa JE; Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network, Bethesda, MD. Maternal BMI, glucose tolerance, and adverse pregnancy outcomes. Am J Obstet Gynecol. 2012 Jul;207(1):62.e1-7. doi: 10.1016/j.ajog.2012.04.035. Epub 2012 May 2.</citation>
    <PMID>22609018</PMID>
  </reference>
  <reference>
    <citation>Berggren EK, Mele L, Landon MB, Spong CY, Ramin SM, Casey B, Wapner RJ, Varner MW, Rouse DJ, Sciscione A, Catalano P, Harper M, Saade G, Caritis SN, Sorokin Y, Peaceman AM, Tolosa JE; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Maternal-Fetal Medicine Units (MFMU) Network. Perinatal outcomes in Hispanic and non-Hispanic white women with mild gestational diabetes. Obstet Gynecol. 2012 Nov;120(5):1099-104. doi: http://10.1097/AOG.0b013e31827049a5.</citation>
    <PMID>23090528</PMID>
  </reference>
  <reference>
    <citation>Ma KK, Mele L, Landon MB, Spong CY, Ramin SM, Casey B, Wapner RJ, Varner MW, Rouse DJ, Thorp JM Jr, Sciscione A, Catalano P, Harper M, Saade G, Caritis SN, Sorokin Y, Peaceman AM; Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. The obstetric and neonatal implications of a low value on the 50-g glucose screening test. Am J Perinatol. 2013 Oct;30(9):715-22. doi: 10.1055/s-0032-1331027. Epub 2012 Dec 27.</citation>
    <PMID>23271384</PMID>
  </reference>
  <reference>
    <citation>Figueroa D, Landon MB, Mele L, Spong CY, Ramin SM, Casey B, Wapner RJ, Varner MW, Thorp JM Jr, Sciscione A, Catalano P, Harper M, Saade G, Caritis SN, Sorokin Y, Peaceman AM, Tolosa JE; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Maternal-Fetal Medicine Units (MFMU) Network. Relationship between 1-hour glucose challenge test results and perinatal outcomes. Obstet Gynecol. 2013 Jun;121(6):1241-7. doi: 10.1097/AOG.0b013e31829277f5.</citation>
    <PMID>23812458</PMID>
  </reference>
  <reference>
    <citation>Costantine MM, Mele L, Landon MB, Spong CY, Ramin SM, Casey B, Wapner RJ, Varner MW, Rouse DJ, Thorp JM Jr, Sciscione A, Catalano P, Caritis SN, Sorokin Y, Peaceman AM, Tolosa JE, Anderson GD; Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network, Bethesda, Maryland. Customized versus population approach for evaluation of fetal overgrowth. Am J Perinatol. 2013 Aug;30(7):565-72. doi: 10.1055/s-0032-1329188. Epub 2012 Nov 12.</citation>
    <PMID>23147078</PMID>
  </reference>
  <reference>
    <citation>Catalano PM, Mele L, Landon MB, Ramin SM, Reddy UM, Casey B, Wapner RJ, Varner MW, Rouse DJ, Thorp JM Jr, Saade G, Sorokin Y, Peaceman AM, Tolosa JE; Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Inadequate weight gain in overweight and obese pregnant women: what is the effect on fetal growth? Am J Obstet Gynecol. 2014 Aug;211(2):137.e1-7. doi: 10.1016/j.ajog.2014.02.004. Epub 2014 Feb 11.</citation>
    <PMID>24530820</PMID>
  </reference>
  <reference>
    <citation>Sutton AL, Mele L, Landon MB, Ramin SM, Varner MW, Thorp JM Jr, Sciscione A, Catalano P, Harper M, Saade G, Caritis SN, Sorokin Y, Grobman WA; Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Delivery timing and cesarean delivery risk in women with mild gestational diabetes mellitus. Am J Obstet Gynecol. 2014 Sep;211(3):244.e1-7. doi: 10.1016/j.ajog.2014.03.005. Epub 2014 Mar 4.</citation>
    <PMID>24607755</PMID>
  </reference>
  <reference>
    <citation>Casey BM, Mele L, Landon MB, Spong CY, Ramin SM, Wapner RJ, Varner MW, Rouse DJ, Thorp JM Jr, Catalano P, Harper M, Saade G, Sorokin Y, Peaceman AM; Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Does maternal body mass index influence treatment effect in women with mild gestational diabetes? Am J Perinatol. 2015 Jan;32(1):93-100. doi: 10.1055/s-0034-1374815. Epub 2014 May 16.</citation>
    <PMID>24839145</PMID>
  </reference>
  <reference>
    <citation>Stuebe AM, Landon MB, Lai Y, Klebanoff M, Ramin SM, Wapner RJ, Varner MW, Rouse DJ, Sciscione A, Catalano P, Saade G, Sorokin Y, Peaceman AM; Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network, Bethesda, MD. Is There a Threshold Oral Glucose Tolerance Test Value for Predicting Adverse Pregnancy Outcome? Am J Perinatol. 2015 Jul;32(9):833-8. doi: 10.1055/s-0034-1543949. Epub 2015 Jan 16.</citation>
    <PMID>25594222</PMID>
  </reference>
  <reference>
    <citation>Palatnik A, Mele L, Landon MB, Reddy UM, Ramin SM, Carpenter MW, Wapner RJ, Varner MW, Rouse DJ, Thorp JM Jr, Sciscione A, Catalano P, Saade GR, Caritis SN, Sorokin Y; Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Timing of treatment initiation for mild gestational diabetes mellitus and perinatal outcomes. Am J Obstet Gynecol. 2015 Oct;213(4):560.e1-8. doi: 10.1016/j.ajog.2015.06.022. Epub 2015 Jun 11.</citation>
    <PMID>26071920</PMID>
  </reference>
  <reference>
    <citation>Rice MM, Landon MB, Varner MW, Casey BM, Reddy UM, Wapner RJ, Rouse DJ, Biggio JR Jr, Thorp JM Jr, Chien EK, Saade G, Peaceman AM, Blackwell SC, VanDorsten JP; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Maternal-Fetal Medicine Units Network (MFMU). Pregnancy-Associated Hypertension in Glucose-Intolerant Pregnancy and Subsequent Metabolic Syndrome. Obstet Gynecol. 2016 Apr;127(4):771-9. doi: 10.1097/AOG.0000000000001353.</citation>
    <PMID>26959208</PMID>
  </reference>
  <reference>
    <citation>Harper LM, Mele L, Landon MB, Carpenter MW, Ramin SM, Reddy UM, Casey B, Wapner RJ, Varner MW, Thorp JM Jr, Sciscione A, Catalano P, Harper M, Saade G, Caritis SN, Sorokin Y, Peaceman AM, Tolosa JE; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Maternal-Fetal Medicine Units (MFMU) Network. Carpenter-Coustan Compared With National Diabetes Data Group Criteria for Diagnosing Gestational Diabetes. Obstet Gynecol. 2016 May;127(5):893-8. doi: 10.1097/AOG.0000000000001383.</citation>
    <PMID>27054932</PMID>
  </reference>
  <reference>
    <citation>Blackwell SC, Landon MB, Mele L, Reddy UM, Casey BM, Wapner RJ, Varner MW, Rouse DJ, Thorp JM Jr, Sciscione A, Catalano P, Saade G, Caritis SN, Sorokin Y, Grobman WA; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Maternal-Fetal Medicine Units (MFMU) Network. Relationship Between Excessive Gestational Weight Gain and Neonatal Adiposity in Women With Mild Gestational Diabetes Mellitus. Obstet Gynecol. 2016 Dec;128(6):1325-1332.</citation>
    <PMID>27824768</PMID>
  </reference>
  <reference>
    <citation>Varner MW, Rice MM, Landon MB, Casey BM, Reddy UM, Wapner RJ, Rouse DJ, Tita AT, Thorp JM, Chien EK, Saade GR, Peaceman AM, Blackwell SC, Vandorsten JP; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Maternal-Fetal Medicine Units (MFMU) Network. Pregnancies After the Diagnosis of Mild Gestational Diabetes Mellitus and Risk of Cardiometabolic Disorders. Obstet Gynecol. 2017 Feb;129(2):273-280. doi: 10.1097/AOG.0000000000001863.</citation>
    <PMID>28079773</PMID>
  </reference>
  <reference>
    <citation>Tita ATN, Lai Y, Landon MB, Ramin SM, Casey B, Wapner RJ, Varner MW, Thorp JM Jr, Sciscione A, Catalano P, Harper M, Saade GR, Caritis SN, Sorokin Y, Peaceman AM, Tolosa JE; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Maternal-Fetal Medicine Units (MFMU) Network. Predictive Characteristics of Elevated 1-Hour Glucose Challenge Test Results for Gestational Diabetes. Am J Perinatol. 2017 Dec;34(14):1464-1469. doi: 10.1055/s-0037-1604243. Epub 2017 Jul 19.</citation>
    <PMID>28724164</PMID>
  </reference>
  <results_reference>
    <citation>Landon MB, Rice MM, Varner MW, Casey BM, Reddy UM, Wapner RJ, Rouse DJ, Biggio JR Jr, Thorp JM, Chien EK, Saade G, Peaceman AM, Blackwell SC, VanDorsten JP; Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units (MFMU) Network. Mild gestational diabetes mellitus and long-term child health. Diabetes Care. 2015 Mar;38(3):445-52. doi: 10.2337/dc14-2159. Epub 2014 Nov 20.</citation>
    <PMID>25414152</PMID>
  </results_reference>
  <results_reference>
    <citation>Landon MB, Spong CY, Thom E, Carpenter MW, Ramin SM, Casey B, Wapner RJ, Varner MW, Rouse DJ, Thorp JM Jr, Sciscione A, Catalano P, Harper M, Saade G, Lain KY, Sorokin Y, Peaceman AM, Tolosa JE, Anderson GB; Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. A multicenter, randomized trial of treatment for mild gestational diabetes. N Engl J Med. 2009 Oct 1;361(14):1339-48. doi: 10.1056/NEJMoa0902430.</citation>
    <PMID>19797280</PMID>
  </results_reference>
  <verification_date>July 2019</verification_date>
  <study_first_submitted>September 29, 2003</study_first_submitted>
  <study_first_submitted_qc>September 29, 2003</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 30, 2003</study_first_posted>
  <results_first_submitted>April 8, 2019</results_first_submitted>
  <results_first_submitted_qc>May 8, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">May 31, 2019</results_first_posted>
  <last_update_submitted>July 11, 2019</last_update_submitted>
  <last_update_submitted_qc>July 11, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">July 15, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Mild gestational diabetes mellitus</keyword>
  <keyword>Maternal Fetal Medicine Units Network</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes, Gestational</mesh_term>
    <mesh_term>Diabetes Mellitus</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>19,665 pregnant women between 24 weeks 0 days and 30 weeks 6 days gestation with glucose levels greater than or equal to 135mg/dl and less than 200 mg/dl after a 1-hour 50-g glucose loading test were assessed for eligibility in the trial. 500 of the eligible patients consented for teh follow-up study.</recruitment_details>
      <pre_assignment_details>Of the women screened, 7,381 consented to participate but 83 did not complete an oral glucose tolerance test. Of the 7,298 women who completed an oral glucose tolerance test, 54 were ineligible, 1,938 were referred for treatment and 4,348 had normal tolerance tests. Thus 958 with abnormal tolerance tests had mild GDM and were randomized.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Nutritional Counseling &amp; Self Blood Glucose Monitoring</title>
          <description>Within one week of enrollment, women in the treatment group receive formal nutritional counseling and will be instructed on the technique of self blood glucose monitoring using a memory-based reflectance meter.
nutritional counseling
self blood glucose monitoring</description>
        </group>
        <group group_id="P2">
          <title>No Treatment</title>
          <description>This group will not receive any specific dietary therapy except for written information concerning general nutritional recommendations for normal pregnancy.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Original Trial</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="485"/>
                <participants group_id="P2" count="473"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="460"/>
                <participants group_id="P2" count="440"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="25"/>
                <participants group_id="P2" count="33"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="25"/>
                <participants group_id="P2" count="33"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
        <period>
          <title>Follow-up Study at 5-10 Years</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="460"/>
                <participants group_id="P2" count="440"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="264"/>
                <participants group_id="P2" count="236"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="196"/>
                <participants group_id="P2" count="204"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Not eligible or did not consent</title>
              <participants_list>
                <participants group_id="P1" count="196"/>
                <participants group_id="P2" count="204"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Nutritional Counseling &amp; Self Blood Glucose Monitoring</title>
          <description>Within one week of enrollment, women in the treatment group receive formal nutritional counseling and will be instructed on the technique of self blood glucose monitoring using a memory-based reflectance meter.
nutritional counseling
self blood glucose monitoring</description>
        </group>
        <group group_id="B2">
          <title>No Treatment</title>
          <description>This group will not receive any specific dietary therapy except for written information concerning general nutritional recommendations for normal pregnancy.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="485"/>
            <count group_id="B2" value="473"/>
            <count group_id="B3" value="958"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="29.2" spread="5.7"/>
                    <measurement group_id="B2" value="28.9" spread="5.6"/>
                    <measurement group_id="B3" value="29.1" spread="5.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="485"/>
                    <measurement group_id="B2" value="473"/>
                    <measurement group_id="B3" value="958"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Ethnic Groups</title>
              <category_list>
                <category>
                  <title>Black</title>
                  <measurement_list>
                    <measurement group_id="B1" value="56"/>
                    <measurement group_id="B2" value="54"/>
                    <measurement group_id="B3" value="110"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="123"/>
                    <measurement group_id="B2" value="119"/>
                    <measurement group_id="B3" value="242"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="22"/>
                    <measurement group_id="B2" value="28"/>
                    <measurement group_id="B3" value="50"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Hispanic</title>
                  <measurement_list>
                    <measurement group_id="B1" value="281"/>
                    <measurement group_id="B2" value="265"/>
                    <measurement group_id="B3" value="546"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Other</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Primigravida</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="104"/>
                    <measurement group_id="B2" value="123"/>
                    <measurement group_id="B3" value="227"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Smoking</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="38"/>
                    <measurement group_id="B2" value="31"/>
                    <measurement group_id="B3" value="69"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Alcohol Use</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="23"/>
                    <measurement group_id="B2" value="11"/>
                    <measurement group_id="B3" value="34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Body-mass Index at Entry</title>
          <units>kg/m^2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="30.1" spread="5.0"/>
                    <measurement group_id="B2" value="30.2" spread="5.1"/>
                    <measurement group_id="B3" value="30.1" spread="5.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Glucose level after 50-g glucose-loading test - mg/dL</title>
          <units>mg/dL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="159.0" spread="15.3"/>
                    <measurement group_id="B2" value="159.7" spread="15.5"/>
                    <measurement group_id="B3" value="159.3" spread="15.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Duration of gestation randomization</title>
          <units>weeks</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="28.8" spread="1.6"/>
                    <measurement group_id="B2" value="28.9" spread="1.5"/>
                    <measurement group_id="B3" value="28.8" spread="1.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Glucose levels in 3-hr Oral Glucose Tolerance Test (OGTT) -mg/dL</title>
          <units>mg/Dl</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <title>Fasting</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="86.6" spread="5.7"/>
                    <measurement group_id="B2" value="86.3" spread="5.7"/>
                    <measurement group_id="B3" value="86.5" spread="5.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1-hour</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="191.8" spread="21.9"/>
                    <measurement group_id="B2" value="193.4" spread="19.3"/>
                    <measurement group_id="B3" value="192.6" spread="20.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2-hour</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="173.7" spread="21.8"/>
                    <measurement group_id="B2" value="173.3" spread="19.6"/>
                    <measurement group_id="B3" value="173.5" spread="20.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3-hour</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="137.3" spread="29.0"/>
                    <measurement group_id="B2" value="134.1" spread="31.5"/>
                    <measurement group_id="B3" value="135.7" spread="30.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With Composite Neonatal Morbidity</title>
        <description>The composite perinatal outcome included stillbirth, neonatal death, hypoglycemia, hyperbilirubinemia, elevated cordblood C-peptide level, and birth trauma.</description>
        <time_frame>Delivery through discharge of infant from hospital up to 120 days</time_frame>
        <population>The results of some blood tests were not available either because samples were not obtained or were not obtained according to protocol or because they could not be assayed owing to a laboratory processing error. Data were not available in some cases because some women delivered at outside institutions.</population>
        <group_list>
          <group group_id="O1">
            <title>Nutritional Counseling &amp; Self Blood Glucose Monitoring</title>
            <description>Within one week of enrollment, women in the treatment group receive formal nutritional counseling and will be instructed on the technique of self blood glucose monitoring using a memory-based reflectance meter.
nutritional counseling
self blood glucose monitoring</description>
          </group>
          <group group_id="O2">
            <title>No Treatment</title>
            <description>This group will not receive any specific dietary therapy except for written information concerning general nutritional recommendations for normal pregnancy.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Composite Neonatal Morbidity</title>
          <description>The composite perinatal outcome included stillbirth, neonatal death, hypoglycemia, hyperbilirubinemia, elevated cordblood C-peptide level, and birth trauma.</description>
          <population>The results of some blood tests were not available either because samples were not obtained or were not obtained according to protocol or because they could not be assayed owing to a laboratory processing error. Data were not available in some cases because some women delivered at outside institutions.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="485"/>
                <count group_id="O2" value="473"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Composite End Point Total</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="460"/>
                    <count group_id="O2" value="440"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="149"/>
                    <measurement group_id="O2" value="163"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hypoglycemia</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="381"/>
                    <count group_id="O2" value="357"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="62"/>
                    <measurement group_id="O2" value="55"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hyperbilirubinemia</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="450"/>
                    <count group_id="O2" value="418"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="43"/>
                    <measurement group_id="O2" value="54"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Elevated cord-blood C-peptide level</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="423"/>
                    <count group_id="O2" value="403"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="75"/>
                    <measurement group_id="O2" value="92"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Stillbirth or Neonatal Death</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="485"/>
                    <count group_id="O2" value="473"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Birth Trauma</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="476"/>
                    <count group_id="O2" value="455"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>For Total Composite End Point</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.14</p_value>
            <method>Chi-squared</method>
            <param_type>Risk Ratio (RR)</param_type>
            <param_value>0.87</param_value>
            <ci_percent>97</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.72</ci_lower_limit>
            <ci_upper_limit>1.07</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Analysis for Hypoglycemia</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.75</p_value>
            <method>Chi-squared</method>
            <param_type>Risk Ratio (RR)</param_type>
            <param_value>1.06</param_value>
            <ci_percent>97</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.73</ci_lower_limit>
            <ci_upper_limit>1.53</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Analysis for hyperbilirubinemia</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.12</p_value>
            <method>Chi-squared</method>
            <param_type>Risk Ratio (RR)</param_type>
            <param_value>0.74</param_value>
            <ci_percent>97</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.49</ci_lower_limit>
            <ci_upper_limit>1.12</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Analysis for elevated cord-blood C-peptide level</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.07</p_value>
            <method>Chi-squared</method>
            <param_type>Risk Ratio (RR)</param_type>
            <param_value>0.78</param_value>
            <ci_percent>97</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.57</ci_lower_limit>
            <ci_upper_limit>1.05</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Analysis for birth trauma</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.33</p_value>
            <method>Chi-squared</method>
            <param_type>Risk Ratio (RR)</param_type>
            <param_value>0.48</param_value>
            <ci_percent>97</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.10</ci_lower_limit>
            <ci_upper_limit>2.20</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Children at the 5-10 Year Followup With BMI ≥ 95th Percentile for Age and Sex</title>
        <description>Number of children with BMI ≥ 95th percentile for age and sex. BMI is measured as kg / m^2. Standards based on the 2000 Centers for Disease Control growth charts.</description>
        <time_frame>Age 5-10 years</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Nutritional Counseling &amp; Self Blood Glucose Monitoring</title>
            <description>Within one week of enrollment, women in the treatment group receive formal nutritional counseling and will be instructed on the technique of self blood glucose monitoring using a memory-based reflectance meter.
nutritional counseling
self blood glucose monitoring</description>
          </group>
          <group group_id="O2">
            <title>No Treatment</title>
            <description>This group will not receive any specific dietary therapy except for written information concerning general nutritional recommendations for normal pregnancy.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Children at the 5-10 Year Followup With BMI ≥ 95th Percentile for Age and Sex</title>
          <description>Number of children with BMI ≥ 95th percentile for age and sex. BMI is measured as kg / m^2. Standards based on the 2000 Centers for Disease Control growth charts.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="264"/>
                <count group_id="O2" value="236"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="55"/>
                    <measurement group_id="O2" value="54"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <param_type>Risk Ratio (RR)</param_type>
            <param_value>0.94</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.68</ci_lower_limit>
            <ci_upper_limit>1.28</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Neonates Who Were Large for Gestational Age at Delivery</title>
        <time_frame>From time of randomization through delivery (up to 17 weeks)</time_frame>
        <population>There were 8 women in the treatment group and 19 women in the control group for whom at least some delivery data were missing</population>
        <group_list>
          <group group_id="O1">
            <title>Nutritional Counseling &amp; Self Blood Glucose Monitoring</title>
            <description>Within one week of enrollment, women in the treatment group receive formal nutritional counseling and will be instructed on the technique of self blood glucose monitoring using a memory-based reflectance meter.
nutritional counseling
self blood glucose monitoring</description>
          </group>
          <group group_id="O2">
            <title>No Treatment</title>
            <description>This group will not receive any specific dietary therapy except for written information concerning general nutritional recommendations for normal pregnancy.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Neonates Who Were Large for Gestational Age at Delivery</title>
          <population>There were 8 women in the treatment group and 19 women in the control group for whom at least some delivery data were missing</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="477"/>
                <count group_id="O2" value="454"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="34"/>
                    <measurement group_id="O2" value="66"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <method>Chi-squared</method>
            <param_type>Risk Ratio (RR)</param_type>
            <param_value>0.49</param_value>
            <ci_percent>97</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.32</ci_lower_limit>
            <ci_upper_limit>0.76</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Neonates With Macrosomia (Birth Weight &gt; 4000 gm)</title>
        <time_frame>Assessed at Delivery</time_frame>
        <population>There were 8 women in the treatment group and 19 women in the control group for whom at least some delivery data were missing</population>
        <group_list>
          <group group_id="O1">
            <title>Nutritional Counseling &amp; Self Blood Glucose Monitoring</title>
            <description>Within one week of enrollment, women in the treatment group receive formal nutritional counseling and will be instructed on the technique of self blood glucose monitoring using a memory-based reflectance meter.
nutritional counseling
self blood glucose monitoring</description>
          </group>
          <group group_id="O2">
            <title>No Treatment</title>
            <description>This group will not receive any specific dietary therapy except for written information concerning general nutritional recommendations for normal pregnancy.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Neonates With Macrosomia (Birth Weight &gt; 4000 gm)</title>
          <population>There were 8 women in the treatment group and 19 women in the control group for whom at least some delivery data were missing</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="477"/>
                <count group_id="O2" value="454"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="28"/>
                    <measurement group_id="O2" value="65"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <method>Chi-squared</method>
            <param_type>Risk Ratio (RR)</param_type>
            <param_value>0.41</param_value>
            <ci_percent>97</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.26</ci_lower_limit>
            <ci_upper_limit>0.66</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number Participants Who Delivered Preterm</title>
        <description>Number of preterm deliveries before 37 weeks gestation</description>
        <time_frame>Delivery before 37 weeks gestation</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Nutritional Counseling &amp; Self Blood Glucose Monitoring</title>
            <description>Within one week of enrollment, women in the treatment group receive formal nutritional counseling and will be instructed on the technique of self blood glucose monitoring using a memory-based reflectance meter.
nutritional counseling
self blood glucose monitoring</description>
          </group>
          <group group_id="O2">
            <title>No Treatment</title>
            <description>This group will not receive any specific dietary therapy except for written information concerning general nutritional recommendations for normal pregnancy.</description>
          </group>
        </group_list>
        <measure>
          <title>Number Participants Who Delivered Preterm</title>
          <description>Number of preterm deliveries before 37 weeks gestation</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="477"/>
                <count group_id="O2" value="455"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="45"/>
                    <measurement group_id="O2" value="53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.27</p_value>
            <method>Chi-squared</method>
            <param_type>Risk Ratio (RR)</param_type>
            <param_value>0.81</param_value>
            <ci_percent>97</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.53</ci_lower_limit>
            <ci_upper_limit>1.23</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Mean Neonatal Fat Mass at Delivery</title>
        <time_frame>Assessed at delivery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Nutritional Counseling &amp; Self Blood Glucose Monitoring</title>
            <description>Within one week of enrollment, women in the treatment group receive formal nutritional counseling and will be instructed on the technique of self blood glucose monitoring using a memory-based reflectance meter.
nutritional counseling
self blood glucose monitoring</description>
          </group>
          <group group_id="O2">
            <title>No Treatment</title>
            <description>This group will not receive any specific dietary therapy except for written information concerning general nutritional recommendations for normal pregnancy.</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Neonatal Fat Mass at Delivery</title>
          <units>grams</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="485"/>
                <count group_id="O2" value="473"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="427.0" spread="197.9"/>
                    <measurement group_id="O2" value="464.3" spread="222.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.003</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Neonates Who Were Small for Gestational Age</title>
        <description>Birth weight below the 10th percentile</description>
        <time_frame>From time of randomization through delivery (up to 17 weeks)</time_frame>
        <population>There were 8 women in the treatment group and 19 women in the control group for whom at least some delivery data were missing</population>
        <group_list>
          <group group_id="O1">
            <title>Nutritional Counseling &amp; Self Blood Glucose Monitoring</title>
            <description>Within one week of enrollment, women in the treatment group receive formal nutritional counseling and will be instructed on the technique of self blood glucose monitoring using a memory-based reflectance meter.
nutritional counseling
self blood glucose monitoring</description>
          </group>
          <group group_id="O2">
            <title>No Treatment</title>
            <description>This group will not receive any specific dietary therapy except for written information concerning general nutritional recommendations for normal pregnancy.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Neonates Who Were Small for Gestational Age</title>
          <description>Birth weight below the 10th percentile</description>
          <population>There were 8 women in the treatment group and 19 women in the control group for whom at least some delivery data were missing</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="477"/>
                <count group_id="O2" value="455"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="36"/>
                    <measurement group_id="O2" value="29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.49</p_value>
            <method>Chi-squared</method>
            <param_type>Risk Ratio (RR)</param_type>
            <param_value>1.18</param_value>
            <ci_percent>97</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.70</ci_lower_limit>
            <ci_upper_limit>1.99</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Mean Neonatal Birth Weight</title>
        <description>Birth weight in grams</description>
        <time_frame>Assessed at delivery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Nutritional Counseling &amp; Self Blood Glucose Monitoring</title>
            <description>Within one week of enrollment, women in the treatment group receive formal nutritional counseling and will be instructed on the technique of self blood glucose monitoring using a memory-based reflectance meter.
nutritional counseling
self blood glucose monitoring</description>
          </group>
          <group group_id="O2">
            <title>No Treatment</title>
            <description>This group will not receive any specific dietary therapy except for written information concerning general nutritional recommendations for normal pregnancy.</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Neonatal Birth Weight</title>
          <description>Birth weight in grams</description>
          <units>grams</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="485"/>
                <count group_id="O2" value="473"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3302" spread="502.4"/>
                    <measurement group_id="O2" value="3408" spread="589.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Infants Admitted to NICU</title>
        <description>Admission to the Neonatal Intensive Care Unit</description>
        <time_frame>Delivery through hospital discharge up to 120 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Nutritional Counseling &amp; Self Blood Glucose Monitoring</title>
            <description>Within one week of enrollment, women in the treatment group receive formal nutritional counseling and will be instructed on the technique of self blood glucose monitoring using a memory-based reflectance meter.
nutritional counseling
self blood glucose monitoring</description>
          </group>
          <group group_id="O2">
            <title>No Treatment</title>
            <description>This group will not receive any specific dietary therapy except for written information concerning general nutritional recommendations for normal pregnancy.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Infants Admitted to NICU</title>
          <description>Admission to the Neonatal Intensive Care Unit</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="477"/>
                <count group_id="O2" value="455"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="43"/>
                    <measurement group_id="O2" value="53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.19</p_value>
            <method>Chi-squared</method>
            <param_type>Risk Ratio (RR)</param_type>
            <param_value>0.77</param_value>
            <ci_percent>97</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.51</ci_lower_limit>
            <ci_upper_limit>1.18</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Neonates Who Received Intravenous Glucose Treatment</title>
        <description>Number of neonates who received intravenous glucose treatment at any time from delivery through hospital discharge.</description>
        <time_frame>Delivery through hospital discharge up to 120 days</time_frame>
        <population>Data was missing for 10 infants in the treatment group and 18 infants in the control group.</population>
        <group_list>
          <group group_id="O1">
            <title>Nutritional Counseling &amp; Self Blood Glucose Monitoring</title>
            <description>Within one week of enrollment, women in the treatment group receive formal nutritional counseling and will be instructed on the technique of self blood glucose monitoring using a memory-based reflectance meter.
nutritional counseling
self blood glucose monitoring</description>
          </group>
          <group group_id="O2">
            <title>No Treatment</title>
            <description>This group will not receive any specific dietary therapy except for written information concerning general nutritional recommendations for normal pregnancy.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Neonates Who Received Intravenous Glucose Treatment</title>
          <description>Number of neonates who received intravenous glucose treatment at any time from delivery through hospital discharge.</description>
          <population>Data was missing for 10 infants in the treatment group and 18 infants in the control group.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="475"/>
                <count group_id="O2" value="455"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="25"/>
                    <measurement group_id="O2" value="31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.32</p_value>
            <method>Chi-squared</method>
            <param_type>Risk Ratio (RR)</param_type>
            <param_value>0.77</param_value>
            <ci_percent>97</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.44</ci_lower_limit>
            <ci_upper_limit>1.36</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Neonates Who Experienced Respiratory Distress Syndrome</title>
        <description>Number of neonates who experienced Respiratory Distress Syndrome at any time from delivery through hospital discharge</description>
        <time_frame>Delivery through hospital discharge up to 120 days</time_frame>
        <population>Data was missing for 8 infants in the treatment group and 18 infants in the control group.</population>
        <group_list>
          <group group_id="O1">
            <title>Nutritional Counseling &amp; Self Blood Glucose Monitoring</title>
            <description>Within one week of enrollment, women in the treatment group receive formal nutritional counseling and will be instructed on the technique of self blood glucose monitoring using a memory-based reflectance meter.
nutritional counseling
self blood glucose monitoring</description>
          </group>
          <group group_id="O2">
            <title>No Treatment</title>
            <description>This group will not receive any specific dietary therapy except for written information concerning general nutritional recommendations for normal pregnancy.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Neonates Who Experienced Respiratory Distress Syndrome</title>
          <description>Number of neonates who experienced Respiratory Distress Syndrome at any time from delivery through hospital discharge</description>
          <population>Data was missing for 8 infants in the treatment group and 18 infants in the control group.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="477"/>
                <count group_id="O2" value="455"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9"/>
                    <measurement group_id="O2" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.33</p_value>
            <method>Chi-squared</method>
            <param_type>Risk Ratio (RR)</param_type>
            <param_value>0.66</param_value>
            <ci_percent>97</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.26</ci_lower_limit>
            <ci_upper_limit>1.67</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants Who Underwent Labor Induction</title>
        <description>Number of participants who underwent labor induction</description>
        <time_frame>From time of randomization through induction (up to 17 weeks)</time_frame>
        <population>Data was missing for 9 women in the treatment group and 18 women in the control group.</population>
        <group_list>
          <group group_id="O1">
            <title>Nutritional Counseling &amp; Self Blood Glucose Monitoring</title>
            <description>Within one week of enrollment, women in the treatment group receive formal nutritional counseling and will be instructed on the technique of self blood glucose monitoring using a memory-based reflectance meter.
nutritional counseling
self blood glucose monitoring</description>
          </group>
          <group group_id="O2">
            <title>No Treatment</title>
            <description>This group will not receive any specific dietary therapy except for written information concerning general nutritional recommendations for normal pregnancy.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Who Underwent Labor Induction</title>
          <description>Number of participants who underwent labor induction</description>
          <population>Data was missing for 9 women in the treatment group and 18 women in the control group.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="476"/>
                <count group_id="O2" value="455"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="130"/>
                    <measurement group_id="O2" value="122"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.86</p_value>
            <method>Chi-squared</method>
            <param_type>Risk Ratio (RR)</param_type>
            <param_value>1.02</param_value>
            <ci_percent>97</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.81</ci_lower_limit>
            <ci_upper_limit>1.29</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants Who Underwent Cesarean Delivery</title>
        <description>Delivery by cesarean section</description>
        <time_frame>Delivery</time_frame>
        <population>Data was missing for 9 women in the treatment group and 18 women in the control group.</population>
        <group_list>
          <group group_id="O1">
            <title>Nutritional Counseling &amp; Self Blood Glucose Monitoring</title>
            <description>Within one week of enrollment, women in the treatment group receive formal nutritional counseling and will be instructed on the technique of self blood glucose monitoring using a memory-based reflectance meter.
nutritional counseling
self blood glucose monitoring</description>
          </group>
          <group group_id="O2">
            <title>No Treatment</title>
            <description>This group will not receive any specific dietary therapy except for written information concerning general nutritional recommendations for normal pregnancy.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Who Underwent Cesarean Delivery</title>
          <description>Delivery by cesarean section</description>
          <population>Data was missing for 9 women in the treatment group and 18 women in the control group.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="476"/>
                <count group_id="O2" value="455"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="128"/>
                    <measurement group_id="O2" value="154"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.02</p_value>
            <method>Chi-squared</method>
            <param_type>Risk Ratio (RR)</param_type>
            <param_value>0.79</param_value>
            <ci_percent>97</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.64</ci_lower_limit>
            <ci_upper_limit>0.99</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Neonates Who Experienced Shoulder Dystocia</title>
        <description>Number of neonates who experienced shoulder dystocia during labor and delivery</description>
        <time_frame>During the process of labor through delivery</time_frame>
        <population>Data was missing for 9 women in the treatment group and 18 women in the control group.</population>
        <group_list>
          <group group_id="O1">
            <title>Nutritional Counseling &amp; Self Blood Glucose Monitoring</title>
            <description>Within one week of enrollment, women in the treatment group receive formal nutritional counseling and will be instructed on the technique of self blood glucose monitoring using a memory-based reflectance meter.
nutritional counseling
self blood glucose monitoring</description>
          </group>
          <group group_id="O2">
            <title>No Treatment</title>
            <description>This group will not receive any specific dietary therapy except for written information concerning general nutritional recommendations for normal pregnancy.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Neonates Who Experienced Shoulder Dystocia</title>
          <description>Number of neonates who experienced shoulder dystocia during labor and delivery</description>
          <population>Data was missing for 9 women in the treatment group and 18 women in the control group.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="476"/>
                <count group_id="O2" value="455"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7"/>
                    <measurement group_id="O2" value="18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.02</p_value>
            <method>Chi-squared</method>
            <param_type>Risk Ratio (RR)</param_type>
            <param_value>0.37</param_value>
            <ci_percent>97</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.14</ci_lower_limit>
            <ci_upper_limit>0.97</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants Who Experienced Preeclampsia</title>
        <description>Number of participants who experienced preeclampsia</description>
        <time_frame>From time of randomization through delivery (up to 17 weeks)</time_frame>
        <population>Data was missing for 9 women in the treatment group and 18 women in the control group.</population>
        <group_list>
          <group group_id="O1">
            <title>Nutritional Counseling &amp; Self Blood Glucose Monitoring</title>
            <description>Within one week of enrollment, women in the treatment group receive formal nutritional counseling and will be instructed on the technique of self blood glucose monitoring using a memory-based reflectance meter.
nutritional counseling
self blood glucose monitoring</description>
          </group>
          <group group_id="O2">
            <title>No Treatment</title>
            <description>This group will not receive any specific dietary therapy except for written information concerning general nutritional recommendations for normal pregnancy.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Who Experienced Preeclampsia</title>
          <description>Number of participants who experienced preeclampsia</description>
          <population>Data was missing for 9 women in the treatment group and 18 women in the control group.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="476"/>
                <count group_id="O2" value="455"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12"/>
                    <measurement group_id="O2" value="25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.02</p_value>
            <method>Chi-squared</method>
            <param_type>Risk Ratio (RR)</param_type>
            <param_value>0.46</param_value>
            <ci_percent>97</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.22</ci_lower_limit>
            <ci_upper_limit>0.97</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants Who Had Preeclampsia or Gestational Hypertension</title>
        <description>Number of participants who had Preeclampsia or gestational hypertension</description>
        <time_frame>From time of randomization through delivery (up to 17 weeks)</time_frame>
        <population>Data was missing for 9 women in the treatment group and 18 women in the control group.</population>
        <group_list>
          <group group_id="O1">
            <title>Nutritional Counseling &amp; Self Blood Glucose Monitoring</title>
            <description>Within one week of enrollment, women in the treatment group receive formal nutritional counseling and will be instructed on the technique of self blood glucose monitoring using a memory-based reflectance meter.
nutritional counseling
self blood glucose monitoring</description>
          </group>
          <group group_id="O2">
            <title>No Treatment</title>
            <description>This group will not receive any specific dietary therapy except for written information concerning general nutritional recommendations for normal pregnancy.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Who Had Preeclampsia or Gestational Hypertension</title>
          <description>Number of participants who had Preeclampsia or gestational hypertension</description>
          <population>Data was missing for 9 women in the treatment group and 18 women in the control group.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="476"/>
                <count group_id="O2" value="455"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="41"/>
                    <measurement group_id="O2" value="62"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.01</p_value>
            <method>Chi-squared</method>
            <param_type>Risk Ratio (RR)</param_type>
            <param_value>0.63</param_value>
            <ci_percent>97</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.42</ci_lower_limit>
            <ci_upper_limit>0.96</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Mean Maternal Body-mass Index at Delivery</title>
        <description>Mean maternal body-mass index at the time of delivery</description>
        <time_frame>Delivery</time_frame>
        <population>Data was missing for 9 women in the treatment group and 18 women in the control group.</population>
        <group_list>
          <group group_id="O1">
            <title>Nutritional Counseling &amp; Self Blood Glucose Monitoring</title>
            <description>Within one week of enrollment, women in the treatment group receive formal nutritional counseling and will be instructed on the technique of self blood glucose monitoring using a memory-based reflectance meter.
nutritional counseling
self blood glucose monitoring</description>
          </group>
          <group group_id="O2">
            <title>No Treatment</title>
            <description>This group will not receive any specific dietary therapy except for written information concerning general nutritional recommendations for normal pregnancy.</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Maternal Body-mass Index at Delivery</title>
          <description>Mean maternal body-mass index at the time of delivery</description>
          <population>Data was missing for 9 women in the treatment group and 18 women in the control group.</population>
          <units>kg/m^2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="476"/>
                <count group_id="O2" value="455"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="31.3" spread="5.2"/>
                    <measurement group_id="O2" value="32.3" spread="5.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Mean Maternal Weight Gain</title>
        <description>Mean Maternal weight gain from enrollment in the trial until delivery</description>
        <time_frame>From time of randomization through delivery (up to 17 weeks)</time_frame>
        <population>Data was missing for 9 women in the treatment group and 18 women in the control group.</population>
        <group_list>
          <group group_id="O1">
            <title>Nutritional Counseling &amp; Self Blood Glucose Monitoring</title>
            <description>Within one week of enrollment, women in the treatment group receive formal nutritional counseling and will be instructed on the technique of self blood glucose monitoring using a memory-based reflectance meter.
nutritional counseling
self blood glucose monitoring</description>
          </group>
          <group group_id="O2">
            <title>No Treatment</title>
            <description>This group will not receive any specific dietary therapy except for written information concerning general nutritional recommendations for normal pregnancy.</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Maternal Weight Gain</title>
          <description>Mean Maternal weight gain from enrollment in the trial until delivery</description>
          <population>Data was missing for 9 women in the treatment group and 18 women in the control group.</population>
          <units>kilograms</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="476"/>
                <count group_id="O2" value="455"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.8" spread="4.5"/>
                    <measurement group_id="O2" value="5.0" spread="3.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Children With BMI ≥ 85th Percentile for Age and Sex</title>
        <description>Number of children with BMI ≥ 85th percentile for age and sex at the 5-10 year follow-up. BMI is measured as kg/m^2. Standards base on the 2000 Centers for Disease Control growth charts.</description>
        <time_frame>Age 5-10 years</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Nutritional Counseling &amp; Self Blood Glucose Monitoring</title>
            <description>Within one week of enrollment, women in the treatment group receive formal nutritional counseling and will be instructed on the technique of self blood glucose monitoring using a memory-based reflectance meter.
nutritional counseling
self blood glucose monitoring</description>
          </group>
          <group group_id="O2">
            <title>No Treatment</title>
            <description>This group will not receive any specific dietary therapy except for written information concerning general nutritional recommendations for normal pregnancy.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Children With BMI ≥ 85th Percentile for Age and Sex</title>
          <description>Number of children with BMI ≥ 85th percentile for age and sex at the 5-10 year follow-up. BMI is measured as kg/m^2. Standards base on the 2000 Centers for Disease Control growth charts.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="264"/>
                <count group_id="O2" value="236"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="86"/>
                    <measurement group_id="O2" value="91"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <param_type>Risk Ratio (RR)</param_type>
            <param_value>0.88</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.71</ci_lower_limit>
            <ci_upper_limit>1.10</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Children at 5-10 Year Follow up With Waist Circumference &gt;90th Percentile for Age, Sex and Race/Ethnicity</title>
        <description>Child waist circumference &gt;90th percentile for age, sex and race/ethnicity based on a study examining cross-sectional data from the Third National Health and Nutrition Examination Survey (NHANES III)</description>
        <time_frame>Age 5-10 years</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Nutritional Counseling &amp; Self Blood Glucose Monitoring</title>
            <description>Within one week of enrollment, women in the treatment group receive formal nutritional counseling and will be instructed on the technique of self blood glucose monitoring using a memory-based reflectance meter.
nutritional counseling
self blood glucose monitoring</description>
          </group>
          <group group_id="O2">
            <title>No Treatment</title>
            <description>This group will not receive any specific dietary therapy except for written information concerning general nutritional recommendations for normal pregnancy.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Children at 5-10 Year Follow up With Waist Circumference &gt;90th Percentile for Age, Sex and Race/Ethnicity</title>
          <description>Child waist circumference &gt;90th percentile for age, sex and race/ethnicity based on a study examining cross-sectional data from the Third National Health and Nutrition Examination Survey (NHANES III)</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="264"/>
                <count group_id="O2" value="236"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="31"/>
                    <measurement group_id="O2" value="27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <param_type>Risk Ratio (RR)</param_type>
            <param_value>1.05</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.65</ci_lower_limit>
            <ci_upper_limit>1.69</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Children at 5-10 Year Follow up With Hypertension ≥ 95th Percentile for Age, Sex and Height</title>
        <description>Hypertension ≥ 95th percentile for age, sex and height based on the National Heart, Lung and Blood Institute Expert Panel on Integrated Guidelines for Children and Adolescents.</description>
        <time_frame>Age 5 - 10 years</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Nutritional Counseling &amp; Self Blood Glucose Monitoring</title>
            <description>Within one week of enrollment, women in the treatment group receive formal nutritional counseling and will be instructed on the technique of self blood glucose monitoring using a memory-based reflectance meter.
nutritional counseling
self blood glucose monitoring</description>
          </group>
          <group group_id="O2">
            <title>No Treatment</title>
            <description>This group will not receive any specific dietary therapy except for written information concerning general nutritional recommendations for normal pregnancy.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Children at 5-10 Year Follow up With Hypertension ≥ 95th Percentile for Age, Sex and Height</title>
          <description>Hypertension ≥ 95th percentile for age, sex and height based on the National Heart, Lung and Blood Institute Expert Panel on Integrated Guidelines for Children and Adolescents.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="264"/>
                <count group_id="O2" value="236"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="30"/>
                    <measurement group_id="O2" value="23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <param_type>Risk Ratio (RR)</param_type>
            <param_value>1.23</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.74</ci_lower_limit>
            <ci_upper_limit>2.05</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Children at 5-10 Year Follow-up With Impaired Fasting Glucose ≥100 mg/dL</title>
        <description>Number of children at 5-10 year follow-up with impaired fasting glucose ≥100 mg/dL</description>
        <time_frame>Age 5-10 years</time_frame>
        <population>The number of children for whom glucose data is available is 390, lower than the larger follow-up sample.</population>
        <group_list>
          <group group_id="O1">
            <title>Nutritional Counseling &amp; Self Blood Glucose Monitoring</title>
            <description>Within one week of enrollment, women in the treatment group receive formal nutritional counseling and will be instructed on the technique of self blood glucose monitoring using a memory-based reflectance meter.
nutritional counseling
self blood glucose monitoring</description>
          </group>
          <group group_id="O2">
            <title>No Treatment</title>
            <description>This group will not receive any specific dietary therapy except for written information concerning general nutritional recommendations for normal pregnancy.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Children at 5-10 Year Follow-up With Impaired Fasting Glucose ≥100 mg/dL</title>
          <description>Number of children at 5-10 year follow-up with impaired fasting glucose ≥100 mg/dL</description>
          <population>The number of children for whom glucose data is available is 390, lower than the larger follow-up sample.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="210"/>
                <count group_id="O2" value="180"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12"/>
                    <measurement group_id="O2" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <param_type>Risk Ratio (RR)</param_type>
            <param_value>0.76</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.36</ci_lower_limit>
            <ci_upper_limit>1.62</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Mean Gestational Age at Birth</title>
        <description>Mean Gestational age at the time of delivery</description>
        <time_frame>Delivery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Nutritional Counseling &amp; Self Blood Glucose Monitoring</title>
            <description>Within one week of enrollment, women in the treatment group receive formal nutritional counseling and will be instructed on the technique of self blood glucose monitoring using a memory-based reflectance meter.
nutritional counseling
self blood glucose monitoring</description>
          </group>
          <group group_id="O2">
            <title>No Treatment</title>
            <description>This group will not receive any specific dietary therapy except for written information concerning general nutritional recommendations for normal pregnancy.</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Gestational Age at Birth</title>
          <description>Mean Gestational age at the time of delivery</description>
          <units>weeks</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="485"/>
                <count group_id="O2" value="473"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="39.0" spread="1.8"/>
                    <measurement group_id="O2" value="38.9" spread="1.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.87</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Data on adverse events for the parent trial was collected from the time of randomization (as early as 24 weeks gestation), through delivery and up to hospital discharge of the infant, death of the infant or 120 days if still hospitalized. Data on adverse events for the follow-up study was collected at the time of the study visit when the child(ren) of the participants were 5-10 years of age.</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Nutritional Counseling &amp; Self Blood Glucose Monitoring</title>
          <description>Within one week of enrollment, women in the treatment group receive formal nutritional counseling and will be instructed on the technique of self blood glucose monitoring using a memory-based reflectance meter.
nutritional counseling
self blood glucose monitoring</description>
        </group>
        <group group_id="E2">
          <title>No Treatment</title>
          <description>This group will not receive any specific dietary therapy except for written information concerning general nutritional recommendations for normal pregnancy.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="485"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="473"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>1</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="485"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="473"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Rebecca Clifton, Ph.D.</name_or_title>
      <organization>GWU Biostatistics Center</organization>
      <phone>(301) 881-9260</phone>
      <email>rclifton@bsc.gwu.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

